The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for ...

Managing blood pressure effectively is a cornerstone of long-term health and wellness. For millions of people, hypertension poses a significant risk to their heart health, often requiring medication ...

Creative arts therapy enriches DBT by using role play to enhance skill-building. Role play helps clients become aware of and ...

Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the launch of the HCR™ Gold and ...

Molecular Instruments® (MI), founded by the inventor of the HCR technology, today announces the launch of the HCR Gold and HCR Pro product lines. These offerings significantly expand the HCR imaging ...

Relapse is common when someone is trying to quit, regardless of whether they're giving up opioids or alcohol or cigarettes.To better inform treatment ...

DelveInsight's Parkinson's disease Psychosis market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

MINNEAPOLIS, MN, UNITED STATES, January 21, 2025 /EINPresswire / -- PowerPatent Unveils Advanced AI Tools to Revolutionize Pharmaceutical Patent Drafting PowerPatent today launched its specialized ...

Arizona officials acknowledged that a fraud scheme targeting Indigenous people with addictions cost taxpayers $2.5 billion.

The initiative will build and power the infrastructure required to digitize and deliver impactful AI-driven pathology solutions to patients and caregivers.

Meaghan Fleischer was thrilled to move into her own eastern Duluth apartment as she worked to stay sober, many months after her release from jail and time spent living with roommates. The 26-year-old ...